In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Kaleb J TysonDivision of Infectious Diseases, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0009-0002-7415-2405 Amanda Z VelezDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27559, USA.ORCID 0000-0001-7007-7394 Blake M HansonCenter for Infectious Diseases, University of Texas Health Science Center, Houston, TX 77030, USA.ORCID 0000-0003-2949-7818 Jianping JiangCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA.ORCID 0000-0002-1066-6362 Kuan-Yi LuDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27559, USA.ORCID 0000-0002-3663-377X Felicia RuffinDivision of Infectious Diseases, Duke University School of Medicine, Durham, NC 27710, USA.
Lauren M BrinkacJ. Craig Venter Institute, Rockville, MD 20850, USA.
Yazhong TaoDivision of Infectious Diseases, Duke University School of Medicine, Durham, NC 27710, USA.
Cesar A AriasDivision of Infectious Diseases, Houston Methodist Hospital and Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX 77030, USA.ORCID 0000-0001-9054-9774 Vance G FowlerDivision of Infectious Diseases, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-8048-0897 Joshua T ThadenDivision of Infectious Diseases, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-3250-0697 Brian P ConlonDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27559, USA.ORCID 0000-0002-2155-8375 Joshua B ParsonsDivision of Infectious Diseases, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-0589-3587 Funding
Microbial Genomic Determinants of Antibiotic Treatment Failure in Staphylococcus aureus BacteremiaK08AI187747 · NIAID · DUKE UNIVERSITY · PI Joshua B Parsons · 2025 to 2026
$380kNIAID NIH HHS K08 AI187747
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
BacteremiaEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsMutationO AntigensAnimalsDisease Models, AnimalHumansLipopolysaccharidesMiceEscherichia coli ProteinsLipopolysaccharidesO Antigens
Identifiers
PMID42384788
PMCPMC13322237
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390